Clinical improvement of severe COVID-19 pneumonia in a pregnant patient after caesarean delivery.
Adult
Anti-Bacterial Agents
/ therapeutic use
Antibodies, Monoclonal, Humanized
/ therapeutic use
Azithromycin
/ therapeutic use
Betacoronavirus
COVID-19
Ceftriaxone
/ therapeutic use
Cesarean Section
Coronavirus Infections
/ drug therapy
Disease Progression
Enzyme Inhibitors
/ therapeutic use
Female
Humans
Hydroxychloroquine
/ therapeutic use
Pandemics
Pneumonia, Viral
/ drug therapy
Postpartum Period
Pregnancy
Pregnancy Complications, Infectious
/ drug therapy
SARS-CoV-2
Treatment Outcome
immunological products and vaccines
infectious diseases
obstetrics and gynaecology
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
16 Jul 2020
16 Jul 2020
Historique:
entrez:
18
7
2020
pubmed:
18
7
2020
medline:
1
8
2020
Statut:
epublish
Résumé
The clinical implications of COVID-19 in pregnancy remain unknown. While preliminary reports demonstrate that pregnant patients have a similar symptomatic presentation to the general population, the appropriate management and timing of delivery in these patients is still unclear, as pregnancy may impose additional risk factors and impede recovery in gravid patients. In this brief report, we present a case of COVID-19 in a pregnant patient with severe respiratory compromise, whose clinical status significantly improved after caesarean delivery. We also address the potential benefits of experimental therapy, including tocilizumab, a monoclonal antibody that targets interleukin-6 receptors.
Identifiants
pubmed: 32675129
pii: 13/7/e236290
doi: 10.1136/bcr-2020-236290
pmc: PMC10577797
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Antibodies, Monoclonal, Humanized
0
Enzyme Inhibitors
0
Hydroxychloroquine
4QWG6N8QKH
Ceftriaxone
75J73V1629
Azithromycin
83905-01-5
tocilizumab
I031V2H011
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Am J Obstet Gynecol. 2020 Jun;222(6):521-531
pubmed: 32217113
Mod Rheumatol. 2016 Sep;26(5):667-71
pubmed: 26873562
Lancet Infect Dis. 2020 May;20(5):559-564
pubmed: 32220284
Obstet Gynecol. 2010 Mar;115(3):669-671
pubmed: 20177305
AJR Am J Roentgenol. 2020 Jul;215(1):127-132
pubmed: 32186894
Clin Infect Dis. 2020 Jul 28;71(15):844-846
pubmed: 32119083
Int J Gynaecol Obstet. 2020 May;149(2):130-136
pubmed: 32196655
Diabetes Res Clin Pract. 2020 Apr;162:108142
pubmed: 32278764
Korean J Anesthesiol. 2020 Aug;73(4):347-351
pubmed: 32229802
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
J Infect. 2020 Mar 5;:
pubmed: 32145216
Cochrane Database Syst Rev. 2017 Mar 21;3:CD004454
pubmed: 28321847
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
Transl Pediatr. 2020 Feb;9(1):51-60
pubmed: 32154135
Arch Pathol Lab Med. 2020 Jul 1;144(7):799-805
pubmed: 32180426
Semin Arthritis Rheum. 2016 Oct;46(2):238-245
pubmed: 27346577
Int J Gynaecol Obstet. 2020 Jun;149(3):273-286
pubmed: 32248521